A 2-Year, Open-Label, Safety Extension Study of Gevokizu

Project: Research project

Project Details

Description

A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Patients with Pyoderma Gangrensoum
StatusFinished
Effective start/end date1/1/1512/31/18

Funding

  • XOMA Corporation

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.